Indian researchers develop new peptide therapy to treat eye infections

HealthIANS
Advertisement
New Delhi, Dec 18 : A team of researchers from Bose Institute in Kolkata has developed a peptide therapy that offers a promising, multidisciplinary approach to treating fungal keratitis -- a severe, sight-threatening infection of the cornea -- the clear front part of the eye.

The team, including researchers from the L V Prasad Eye Institute in Hyderabad, designed a 15-residue peptide, named SA-XV, derived from a larger host-defense peptide -- S100A12. This peptide, previously shown to inhibit fungal growth, has been characterised for its antifungal potency and mechanism of action.

Published in the Journal of Biological Chemistry, the researchers hailed the new therapy as an alternative to antimycotics (antifungals) with reduced side effects.

Corneal infections, often referred to as a slow epidemic, affect a significant portion of the population in India, particularly among those with agricultural backgrounds. Overuse and poor hygiene practices related to contact lenses are also a major contributor to corneal infections.

Currently, amphotericin B is the only drug available to treat fungal infections. However, its use is limited due to kidney damage and high haemolytic activity, where red blood cells (RBCs) are being destroyed too quickly. This creates an urgent need for the development of potent antimycotic drugs that are safe for mammalian cells.

In mouse models, SA-XV showed a reduction in the severity of keratitis.

“The antimicrobial peptides are non-toxic, serum-stable, and effective in inhibiting the growth of both planktonic and biofilm forms of Fusarium and Candida species,” said the team led by Professor Anirban Bhunia, from Bose Institute, an autonomous institute under the Department of Science and Technology.

“SA-XV works by first interacting with the fungal cell wall and plasma membrane, then it translocates across the cell membrane and accumulates in the cytoplasm. The peptide subsequently colocalises in the nucleus, binding to genomic DNA and halting the cell cycle. Finally, it targets the mitochondria, permeabilises them, and induces fungal cell death through apoptosis,” the researchers explained.

The study highlights that SA-XV is not only an antifungal agent but can also be used for promoting wound healing in corneal infections.

The findings suggest that SA-XV could become a novel therapeutic option for treating fungal infections and accelerating corneal wound healing, offering an alternative to current treatments.
Advertisement

Note: The content of this article is sourced from a news agency and has not been edited by the ap7am team.

Anirban Bhuniapeptide therapyeye infectionsfungal keratitisSA-XV peptidecorneal infectionsantifungal treatmentBose InstituteL V Prasad Eye Institute

More News

Telangana’s 4,000 MW Yadadri plant to achieve full capacity soon

17 Nov, 19:01

Reports of unwanted Instagram recommendations in India halved over past year: Meta

17 Nov, 19:00

Trump watches as PM Modi picks up Indian flag marker from floor, video goes viral

17 Nov, 18:58

Rajinikanth's daughter Soundarya shares pictures of their family getaway in Greece; says 'What amazing memories we’ve made in Athens!'

17 Nov, 18:56

When Jackie Shroff gave 10x returns to Archana Puran Singh on pending principal amount from struggling days

17 Nov, 18:54

'There was no one like Dhoni, and can't see anyone in next 10 years either': Coach MP Singh

17 Nov, 18:53

Dulquer Salmaan's 'Aakasamlo Oka Tara' cleared for release with U/A certificate

17 Nov, 18:52

Gas leak from ONGC well in Andhra brought under control

17 Nov, 18:50

‘Learned the meaning of simplicity…’: Ruturaj Gaikwad’s heartfelt tribute to Dhoni

17 Nov, 18:49

Dhanush, Mammootty-starrer 'Om' cleared for release with U/A certificate!

17 Nov, 18:47

Sri Lanka lose 15 WTC points, Pakistan docked five for slow over-rate during Rawalpindi Test

17 Nov, 18:46

'IPL will not be the same': Cricket fraternity pays emotional tribute to MS Dhoni after retirement

17 Nov, 18:44

Rahul Gandhi responds to backlash over 'lap' remark, shares temple sculpture

17 Nov, 18:43

PM Modi is 'a very tough man': Trump after meeting Quad counterparts

17 Nov, 17:06

Drug cartels turn to private players, DIY videos to evade crackdown; agencies flag new trend

17 Nov, 17:05

Gurnoor Brar reprimanded for Code of Conduct breach, handed one demerit point

17 Nov, 17:03

Why did Telangana find no mention in Sonia Gandhi’s book: BRS

17 Nov, 17:02

MS Dhoni’s IPL legacy: Five titles, 5,439 runs and several records

17 Nov, 16:57

Nifty hits 9-month high, Bank Nifty scales record peak as market rally extends

17 Nov, 16:00

Dhoni quietly said, ‘Maybe you should add my name' in release list, reveals CSK owner Rupa Gurunath

17 Nov, 15:46
..More News